According to Cooper Companies's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 16.1316. At the end of 2022 the company had a P/E ratio of 42.2.
Year | P/E ratio | Change |
---|---|---|
2022 | 42.2 | 504.05% |
2021 | 6.99 | -90.66% |
2020 | 74.9 | 120.5% |
2019 | 33.9 | -62.19% |
2018 | 89.8 | 214.22% |
2017 | 28.6 | -7.87% |
2016 | 31.0 | -2.94% |
2015 | 32.0 | 10.78% |
2014 | 28.8 | 42.22% |
2013 | 20.3 | 13.49% |
2012 | 17.9 | -5.47% |
2011 | 18.9 | -16.78% |
2010 | 22.7 | 32.9% |
2009 | 17.1 | 52.18% |
2008 | 11.2 | -107.39% |
2007 | -152 | -608.94% |
2006 | 29.9 | 17.85% |
2005 | 25.3 | 2.11% |
2004 | 24.8 | 15.85% |
2003 | 21.4 | 37% |
2002 | 15.6 | -21.78% |
2001 | 20.0 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 10.3 | -36.29% | ๐บ๐ธ USA |
Novartis NVS | 24.9 | 54.28% | ๐จ๐ญ Switzerland |
Boston Scientific BSX | 82.9 | 413.76% | ๐บ๐ธ USA |
Teleflex TFX | 24.2 | 50.15% | ๐บ๐ธ USA |
Utah Medical Products UTMD | 14.5 | -9.91% | ๐บ๐ธ USA |
Atrion ATRI | 26.0 | 60.93% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.